February 15, 2022 06:55 AM EST

Amgen comes in second with its latest batch of KRAS data, but its rival is still having problems catching up

Amgen once again finds itself touting KRAS G12C data that don’t measure up to a rival at Mirati, as the smaller player struggles to play …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Am­gen comes in sec­ond with its lat­est batch of KRAS da­ta, but its ri­val is still hav­ing prob­lems catch­ing up